BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

The second blank-check vehicle from Cormorant’s Bihua Chen plans to take BridgeBio’s oncology spinout onto the Nasdaq.

The special purpose acquisition company — known as Helix …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Opinion | Will a CEO’s Murder Nudge American Healthcare Toward the Unthinkable?

Ron Harman King is CEO of Vanguard Communications, a healthcare marketing and practice management consulting firm, and author of “The Totally Wired Doctor: Social Media,

January 6, 2025

Will MAHA add alcohol to its list of health foes?

Robert F. Kennedy Jr. and his allies in the “Make America Healthy Again” movement have no shortage of targets — products, policies, foods and drinks

January 14, 2025

TDR’s Top 5 Psychedelic Developments For The Week Of October 23

Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of October 23. Aside from presenting a synopsis of events, we provide

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.